Inventor · disambiguated record
Katrina Chan
Also filed as: CHAN KATRINA
47 granted patents·19 pending applications·924 citations·filing 2009–2025
98Inventor score
Files withINTELLIKINE LLC25REN PINGDA15INFINITY PHARMACEUTICALS INC11PLEXXIKON INC6CASTRO ALFREDO C3
Top patents by PatentIndex Score
66 records- 0198US8569323B2Substituted isoquinolin-1(2H)-one compounds, compositions, and methods thereofREN PINGDA·Filed 2012·Granted Oct 29, 2013·61 cites·14 claims
- 0298US8193182B2Substituted isoquinolin-1(2H)-ones, and methods of use thereofREN PINGDA·Filed 2009·Granted Jun 5, 2012·93 cites·39 claims
- 0397US9181221B2Chemical compounds, compositions and methods for kinase modulationINFINITY PHARMACEUTICALS INC·Filed 2013·Granted Nov 10, 2015·64 cites·18 claims
- 0497US9096611B2Kinase inhibitors and methods of useREN PINGDA·Filed 2009·Granted Aug 4, 2015·65 cites·11 claims
- 0597US8785470B2Heterocyclic compounds and uses thereofCASTRO ALFREDO C·Filed 2012·Granted Jul 22, 2014·41 cites·24 claims
- 0697US8604032B2Chemical compounds, compositions and methods for kinase modulationREN PINGDA·Filed 2011·Granted Dec 10, 2013·48 cites·42 claims
- 0796US9085560B2Heterocyclic compounds and uses thereofREN PINGDA·Filed 2010·Granted Jul 21, 2015·37 cites·12 claims
- 0896US8969363B2Heterocyclic compounds and uses thereofCASTRO ALFREDO C·Filed 2012·Granted Mar 3, 2015·44 cites·56 claims
- 0996US8940742B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2013·Granted Jan 27, 2015·35 cites·48 claims
- 1096US8901133B2Heterocyclic compounds and uses thereofREN PINGDA·Filed 2011·Granted Dec 2, 2014·44 cites·54 claims
- 1196US8785456B2Substituted isoquinolin-1(2H)-ones, and methods of use thereofREN PINGDA·Filed 2012·Granted Jul 22, 2014·25 cites·170 claims
- 1296US8703777B2Certain chemical entities, compositions and methodsREN PINGDA·Filed 2009·Granted Apr 22, 2014·36 cites·35 claims
- 1395US9718847B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2014·Granted Aug 1, 2017·33 cites·21 claims
- 1495US9127000B2Heterocyclic compounds and uses thereofREN PINGDA·Filed 2012·Granted Sep 8, 2015·30 cites·9 claims
- 1595US9115141B2Substituted isoquinolinones and methods of treatment thereofINFINITY PHARMACEUTICALS INC·Filed 2013·Granted Aug 25, 2015·27 cites·49 claims
- 1694US9522146B2Substituted Isoquinolin-1(2H)-one compounds, compositions, and methods thereofINTELLIKINE LLC·Filed 2015·Granted Dec 20, 2016·10 cites·24 claims
- 1794US9255108B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Feb 9, 2016·21 cites·45 claims
- 1893US9676748B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Granted Jun 13, 2017·23 cites·20 claims
- 1993US9056877B2Heterocyclic compounds and uses thereofCASTRO ALFREDO C·Filed 2012·Granted Jun 16, 2015·25 cites·32 claims
- 2093US8703778B2Heterocyclic kinase inhibitorsREN PINGDA·Filed 2009·Granted Apr 22, 2014·20 cites·16 claims
- 2192US9938273B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Apr 10, 2018·17 cites·43 claims
- 2292US9388183B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Jul 12, 2016·19 cites·26 claims
- 2391US9629843B2MTOR modulators and uses thereofUNIV CALIFORNIA·Filed 2015·Granted Apr 25, 2017·18 cites·1 claims
- 2491US9216982B2Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2014·Granted Dec 22, 2015·8 cites·28 claims
- 2590US9206182B2Substituted isoquinolin-1(2H)-one compounds, compositions, and methods thereofINTELLIKINE LLC·Filed 2013·Granted Dec 8, 2015·8 cites·27 claims
- 2689US8993580B2Benzothiazole kinase inhibitors and methods of useREN PINGDA·Filed 2009·Granted Mar 31, 2015·11 cites·19 claims
- 2788US10301280B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted May 28, 2019·6 cites·21 claims
- 2888US8476282B2Benzoxazole kinase inhibitors and methods of useREN PINGDA·Filed 2009·Granted Jul 2, 2013·3 cites·31 claims
- 2988US8476431B2Benzoxazole kinase inhibitors and methods of useREN PINGDA·Filed 2009·Granted Jul 2, 2013·3 cites·10 claims
- 3087US9828378B2Kinase inhibitors and methods of useINTELLIKINE LLC·Filed 2015·Granted Nov 28, 2017·6 cites·18 claims
- 3187US8637542B2Kinase inhibitors and methods of useLIU YI·Filed 2009·Granted Jan 28, 2014·10 cites·23 claims
- 3287US2024209000A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2023·Application pending·0 cites
- 3385US9296742B2Heterocyclic kinase inhibitorsINTELLIKINE LLC·Filed 2014·Granted Mar 29, 2016·6 cites·22 claims
- 3484US10519177B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2017·Granted Dec 31, 2019·4 cites·22 claims
- 3584US10227357B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Granted Mar 12, 2019·7 cites·7 claims
- 3682US9096590B2Substituted benzoxazoles as PI3 kinase inhibitorsREN PINGDA·Filed 2011·Granted Aug 4, 2015·5 cites·22 claims
- 3781US9605003B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2015·Granted Mar 28, 2017·3 cites·39 claims
- 3881US2023321050A1Heterocyclic Compounds and Uses ThereofMILLENNIUM PHARM INC·Filed 2022·Application pending·0 cites
- 3980US9345706B2Benzoxazole kinase inhibitors and methods of useINTELLIKINE LLC·Filed 2015·Granted May 24, 2016·1 cites·1 claims
- 4080US2022265637A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2021·Application pending·0 cites
- 4180US2025170122A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2025·Application pending·0 cites
- 4278US11547697B2Heterocyclic compounds and uses thereofMILLENNIUM PHARM INC·Filed 2018·Granted Jan 10, 2023·1 cites·31 claims
- 4378US9655892B2Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2015·Granted May 23, 2017·1 cites·21 claims
- 4478US9637492B2Benzothiazole kinase inhibitors and methods of useINTELLIKINE LLC·Filed 2015·Granted May 2, 2017·2 cites·19 claims
- 4577US11433065B2Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2019·Granted Sep 6, 2022·0 cites·16 claims
- 4677US9546180B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Jan 17, 2017·2 cites·29 claims
- 4774US2022372048A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2020·Application pending·0 cites
- 4873US9790228B2Heterocyclic kinase inhibitorsINTELLIKINE LLC·Filed 2016·Granted Oct 17, 2017·1 cites·10 claims
- 4971US2019290636A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2018·Application pending·0 cites
- 5069US2014128599A1Benzoxazole kinase inhibitors and methods of useIntellikine LLC La Jolla·Filed 2013·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Katrina Chan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →